Talphera (TLPH) Interest Coverage Ratio Growth (3y) (2013 - 2026)
Talphera (TLPH) Interest Coverage Ratio Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | - |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | -3.69% |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | 75.30% |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | -72.71% |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | -2.64% |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | 37.62% |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | Talphera | 90.25 Mn | 90.25 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 47.00% |
| Mar 31, 2026 | -166.65% |
| Dec 31, 2025 | 88.83% |
| Sep 30, 2025 | -44.43% |
| Dec 31, 2024 | 11.68% |
| Sep 30, 2024 | -287.99% |
| Jun 30, 2024 | -274.10% |
| Dec 31, 2023 | 56.63% |
| Sep 30, 2023 | -44.50% |
| Jun 30, 2023 | -73.55% |
| Mar 31, 2023 | 54.34% |
| Dec 31, 2022 | 23.52% |
| Sep 30, 2022 | 32.51% |
| Jun 30, 2022 | -2.25% |
| Mar 31, 2022 | -131.52% |
| Dec 31, 2021 | 3.13% |
| Sep 30, 2021 | 3.09% |
| Jun 30, 2021 | -10.14% |
| Mar 31, 2021 | -1.89% |
| Dec 31, 2020 | 71.26% |